Literature DB >> 15254597

Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas.

Koichi Shimizu1, Masayoshi Shichiri, Peter Libby, Richard T Lee, Richard N Mitchell.   

Abstract

Abdominal aortic aneurysms (AAAs) cause death due to complications related to expansion and rupture. The underlying mechanisms that drive AAA development remain largely unknown. We recently described evidence for a shift toward T helper type 2 (Th2) cell responses in human AAAs compared with stenotic atheromas. To evaluate putative pathways in AAA formation, we induced Th1- or Th2-predominant cytokine environments in an inflammatory aortic lesion using murine aortic transplantation into WT hosts or those lacking the receptors for the hallmark Th1 cytokine IFN-gamma, respectively. Allografts in WT recipients developed intimal hyperplasia, whereas allografts in IFN-gamma receptor-deficient (GRKO) hosts developed severe AAA formation associated with markedly increased levels of MMP-9 and MMP-12. Allografts in GRKO recipients treated with anti-IL-4 antibody to block the characteristic IL-4 Th2 cytokine or allografts in GRKO hosts also congenitally deficient in IL-4 did not develop AAA and likewise exhibited attenuated collagenolytic and elastolytic activities. These observations demonstrate an important dichotomy between cellular immune responses that induce IFN-gamma- or IL-4-dominated cytokine environments. The findings establish important regulatory roles for a Th1/Th2 cytokine balance in modulating matrix remodeling and have important implications for the pathophysiology of AAAs and arteriosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254597      PMCID: PMC449742          DOI: 10.1172/JCI19855

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4.

Authors:  A E Postlethwaite; M A Holness; H Katai; R Raghow
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

2.  T lymphocytes in atherosclerotic lesions.

Authors:  T Watanabe; T Shimokama; S Haraoka; H Kishikawa
Journal:  Ann N Y Acad Sci       Date:  1995-01-17       Impact factor: 5.691

Review 3.  Interplay of T cells and cytokines in the context of enzymatically modified extracellular matrix.

Authors:  D Gilat; L Cahalon; R Hershkoviz; O Lider
Journal:  Immunol Today       Date:  1996-01

4.  Localization of accessory pathways from the 12-lead electrocardiogram using a new algorithm.

Authors:  B Xie; S C Heald; Y Bashir; D Katritsis; F D Murgatroyd; A J Camm; E Rowland; D E Ward
Journal:  Am J Cardiol       Date:  1994-07-15       Impact factor: 2.778

5.  Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms.

Authors:  S D Shapiro; D K Kobayashi; A P Pentland; H G Welgus
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

6.  Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4.

Authors:  S Lacraz; L Nicod; B Galve-de Rochemonteix; C Baumberger; J M Dayer; H G Welgus
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

7.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.

Authors:  R W Thompson; D R Holmes; R A Mertens; S Liao; M D Botney; R P Mecham; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources.

Authors:  K M Newman; A M Malon; R D Shin; J V Scholes; W G Ramey; M D Tilson
Journal:  Connect Tissue Res       Date:  1994       Impact factor: 3.417

9.  In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta.

Authors:  W D McMillan; B K Patterson; R R Keen; V P Shively; M Cipollone; W H Pearce
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-08       Impact factor: 8.311

10.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.

Authors:  T Freestone; R J Turner; A Coady; D J Higman; R M Greenhalgh; J T Powell
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-08       Impact factor: 8.311

View more
  83 in total

1.  Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.

Authors:  Koichi Shimizu; Peter Libby; Viviane Z Rocha; Eduardo J Folco; Rica Shubiki; Nir Grabie; Sunyoung Jang; Andrew H Lichtman; Ayako Shimizu; Nancy Hogg; Daniel I Simon; Richard N Mitchell; Kevin Croce
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice.

Authors:  Jun Xu; Brittney Ehrman; Linda M Graham; Matthew J Eagleton
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

Review 3.  The harms and benefits of inflammatory and immune responses in vascular disease.

Authors:  Angel Chamorro; John Hallenbeck
Journal:  Stroke       Date:  2006-01-12       Impact factor: 7.914

Review 4.  Aortic aneurysms: an immune disease with a strong genetic component.

Authors:  Helena Kuivaniemi; Chris D Platsoucas; M David Tilson
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

Review 5.  Biomarkers of AAA progression. Part 1: extracellular matrix degeneration.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-05-26       Impact factor: 32.419

6.  Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.

Authors:  Haojun Xuan; Baohui Xu; Wei Wang; Hiroki Tanaka; Naoki Fujimura; Masaaki Miyata; Sara A Michie; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2017-04-20       Impact factor: 4.268

7.  CD43-mediated IFN-γ production by CD8+ T cells promotes abdominal aortic aneurysm in mice.

Authors:  Hui-fang Zhou; Huimin Yan; Judy L Cannon; Luke E Springer; Jonathan M Green; Christine T N Pham
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

8.  GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency.

Authors:  Ping Ye; Wenhao Chen; Jie Wu; Xiaofan Huang; Jun Li; Sihua Wang; Zheng Liu; Guohua Wang; Xiao Yang; Peng Zhang; Qiulun Lv; Jiahong Xia
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

9.  Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context?

Authors:  John A Curci; Robert W Thompson
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 10.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.